首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1358036

客製化重组蛋白生产服务市场：按表达系统、最终用户、地区

Custom Recombinant Protein Production Services Market, By Expression System, By End User, By Region

出版日期: 2023年09月14日 | 出版商:

Coherent Market Insights | 英文 207 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2023 年，全球客製化重组蛋白生产服务市场将达到 49 亿美元，预计在预测期内（2023-2030 年）年复合成长率为 11.5%。

报告范围		报告详情
基准年	2022年	2023年市场规模	49亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期年复合成长率	11.50%	2030年市场规模预测	105亿美元

客製化重组蛋白生产服务的全球市场占有率(%)，按表现系统，2023 年

重组蛋白在生物技术、研究和医学领域有广泛的用途。客製化重组蛋白生产是生命科学领域使用的有效技术之一，在先进的医疗保健中发挥重要作用。重组蛋白是透过使用特定技术操纵蛋白质而开发的。然后这些基因被用来编码这些重组蛋白，这些重组蛋白被大量生产并用于製造治疗剂和商业产品。政府在生命科学领域的配合措施和资金的增加预计将促进市场成长。

许多重组蛋白需要并提供转译后修饰，例如仅在真核生物、酵母、哺乳动物和昆虫细胞培养系统中可用的糖基化。 HEK293 衍生细胞株用于瞬时蛋白质生产。目前，大多数重组治疗性蛋白质是在哺乳动物细胞中产生的，因为它们能够产生与自然界中发现的类似的高品质蛋白质。此外，许多核准的重组治疗性蛋白质都是在大肠桿菌中产生的，因为它们具有良好的遗传特征，生长迅速，并且可以高产量生产。

市场动态

预计主要企业越来越多地采用无机成长策略（例如主要参与者的收购）将推动该细分市场在预测期内的成长。例如，2021年7月，经过高度检验的一抗製造商Atlas Antibodies收购了中国仓鼠卵巢（CHO）细胞中瞬时重组抗体表达开发商Evitria。 CHO 细胞是重组治疗蛋白 (RTP) 生产的合适表现系统。此次收购将结合两家公司的抗体解决方案并扩大各自的业务。

本研究的主要特点

本报告详细分析了全球客製化重组蛋白生产服务市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率。
它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球客製化重组蛋白生产服务市场的主要企业。
该报告的见解将使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
全球客製化重组蛋白生产服务市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球客製化重组蛋白生产服务市场的各种策略矩阵来促进他们的决策。

公司简介
- GenScript Biotech Corporation
- SignalChem Biotech Inc.
- Crown Bioscience, Inc.
- BPS Bioscience Inc.
- Novoprotein
- Applied Biological Materials（abm）Inc.
- Eurofins Pharma Discovery Services
- Abgent（WuXi AppTec Company）
- Kempbio, Inc.
- Trenzyme GmbH
- Sino Biological Inc.
- Aragen Bioscience, a GVKBIO Company
- LakePharma, Inc.
- Proteos Inc.
- Icosagen AS
- Novus Biological LLC
- Proteogenix
- Premas Biotech
- ATUM
- Aldevron

第9章章节

参考
调查方法
关于出版商并联络方式我们

简介目录

Product Code: CMI2737

The global custom recombinant protein production services market is estimated to be valued at US$ 4.9 billion in 2023 and is expected to exhibit a CAGR of 11.5% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 4.9 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	11.50%	2030 Value Projection:	US$ 10.5 Bn

Global Custom Recombinant Protein Production Services Market Share (%), By Expression System, 2023

Custom Recombinant Protein Production Services Market - IMG1

Recombinant proteins have a wide range of applications in biotechnology, research, and medicine. Custom recombinant protein production is one of the efficient techniques used in the life sciences sector that plays a major role in advanced healthcare. Recombinant proteins are developed by manipulating proteins using certain techniques. Genes are then used to encode these recombinant proteins, which are then produced in large quantities and used to make therapeutic and commercial products. Increasing government initiatives and funding in the field of life sciences is expected to boost growth of the market.

Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian, and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high-quality proteins similar in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.

Market Dynamics

The increasing adoption of inorganic growth strategies such as acquisitions by the key players is expected to drive segment growth over the forecast period. For instance, in July 2021, Atlas Antibodies, a manufacturer of highly validated primary antibodies, acquired Evitria, a developer of transient recombinant antibody expression in Chinese hamster ovary (CHO) cells. CHO cells are the preferred expression system for recombinant therapeutic protein (RTP) production. The acquisition will combine the antibody solutions of both companies and expand their businesses.

Key features of the study:

This report provides an in-depth analysis of the global custom recombinant protein production services market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global custom recombinant protein production services market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include GenScript Biotech Corporation, SignalChem Biotech Inc., Crown Bioscience, Inc., BPS Bioscience Inc., Novoprotein, Applied Biological Materials (abm) Inc., Eurofins Pharma Discovery Services, Abgent (WuXi AppTec Company), OriGene Technologies, Inc., Kempbio, Inc., Trenzyme GmbH, Sino Biological Inc., Aragen Bioscience, a GVKBIO Company, LakePharma, Inc., , Proteos Inc., Icosagen AS, Novus Biological LLC, Proteogenix, Premas Biotech, ATUM, and Aldevron
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global custom recombinant protein production services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global custom recombinant protein production services market.

Custom Recombinant Protein Production Services Market Detailed Segmentation:

By Expression System:
- Mammalian
- Bacteria
- Insect
- Yeast
- Others
By End User :
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- GenScript Biotech Corporation
- SignalChem Biotech Inc.
- Crown Bioscience, Inc.
- BPS Bioscience Inc.
- Novoprotein
- Applied Biological Materials (abm) Inc.
- Eurofins Pharma Discovery Services
- Abgent (WuXi AppTec Company)
- OriGene Technologies, Inc.
- Kempbio, Inc.
- Trenzyme GmbH
- Sino Biological Inc.
- Aragen Bioscience, a GVKBIO Company
- LakePharma, Inc.,
- Proteos Inc.
- Icosagen AS
- Novus Biological LLC
- Proteogenix
- Premas Biotech
- ATUM
- Aldevron

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Expression System
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Custom Recombinant Protein Production Services Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Custom Recombinant Protein Production Services Market, By Expression System , 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Bacteria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Insect
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Yeast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Custom Recombinant Protein Production Services Market, By End User, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Custom Recombinant Protein Production Services Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Company Profiles
- GenScript Biotech Corporation
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- SignalChem Biotech Inc.
- Crown Bioscience, Inc.
- BPS Bioscience Inc.
- Novoprotein
- Applied Biological Materials (abm) Inc.
- Eurofins Pharma Discovery Services
- Abgent (WuXi AppTec Company)
- Kempbio, Inc.
- Trenzyme GmbH
- Sino Biological Inc.
- Aragen Bioscience, a GVKBIO Company
- LakePharma, Inc.
- Proteos Inc.
- Icosagen AS
- Novus Biological LLC
- Proteogenix
- Premas Biotech
- ATUM
- Aldevron